Sibylle Loibl

Researcher Next ID · RN-001875

Researcher · Biochemistry, Genetics and Molecular Biology

Frankfurt am Main, Germany

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

HER2/EGFR in Cancer Research

Advanced Breast Cancer Therapies

Cancer Treatment and Pharmacology

Cancer Genomics and Diagnostics

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1814017
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(13)62422-8
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu450
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt303
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.8595

No projects listed.